Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 71 5
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 92 22
Interferon alfa Recommended by China's NHC Guidelines Used to treat other disease Antiviral May/12/2021 6 1
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021 14 3
Oseltamivir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/11/2020 5 3
Apilimod Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020 3 0
VBY-825 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0